GNH USA

Europe — EMA

Kleder

GNH USA supplies Kleder (Lenalidomide), a immunomodulatory drug for multiple myeloma and myelodysplastic syndromes. Request a quote for global supply.

Lenalidomide

Request sourcing

1
Pack/s

What is Lenalidomide?

Lenalidomide, the active ingredient in Kleder, is a Immunomodulatory drug (IMiD) presented as a oral tablet for oral use. It treats multiple myeloma and myelodysplastic syndromes in adult patients.

GNH USA supplies Kleder as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Lenalidomide used for?

Lenalidomide is used in hematologic malignancies and related bone‑marrow disorders. - Multiple myeloma: improves progression‑free and overall survival in newly diagnosed patients. - Relapsed or refractory multiple myeloma: provides disease control after prior therapies. - Myelodysplastic syndromes: reduces transfusion dependence and delays transformation to acute leukemia.

What are the side effects of Lenalidomide?

Lenalidomide may cause a range of adverse reactions.

Common Side Effects: - Fatigue: persistent tiredness. - Neutropenia: reduced neutrophil count. - Diarrhea: loose stools. - Rash: skin irritation.

Serious or Rare Side Effects: - Venous thromboembolism: formation of blood clots in veins. - Severe neutropenia: markedly low neutrophil levels increasing infection risk. - Embryo‑fetal toxicity: can cause birth defects and fetal loss.

What precautions apply to Lenalidomide?

Lenalidomide requires careful monitoring and specific safety measures. - Pregnancy contraindication: category X; avoid use in pregnant women. - Thrombosis risk: assess and manage clotting risk, especially with additional risk factors. - Blood count monitoring: perform regular CBC to detect cytopenias. - Renal impairment: adjust dose in patients with reduced kidney function. - Drug interactions: review concomitant medications for additive myelosuppression. - Store below 25°C: keep in the original pack, protect from moisture.

What does Lenalidomide interact with?

Lenalidomide can interact with several drug classes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Immunosuppressants (e.g., cyclosporine): reduced therapeutic effect. - Live vaccines: heightened risk of infection.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may raise lenalidomide exposure. - CYP3A4 inducers (e.g., rifampin): may lower drug levels. - NSAIDs: additive myelosuppressive potential.

Frequently asked questions

What conditions is Kleder used to treat?+
Kleder contains lenalidomide and is prescribed for adult patients with multiple myeloma and myelodysplastic syndromes, including relapsed or refractory disease forms, to improve survival and reduce transfusion needs.
How does lenalidomide work in the body?+
Lenalidomide binds to cereblon, a component of the CRL4‑E3 ubiquitin ligase, leading to degradation of transcription factors Ikaros and Aiolos. This modulates immune responses, inhibits new blood‑vessel formation, and disrupts cytokine signaling, collectively producing anti‑tumor activity.
What is the usual dose of Kleder?+
The specific dose of Kleder is determined by the prescribing clinician based on the patient’s diagnosis, disease stage, renal function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Kleder safe to use during pregnancy or breastfeeding?+
Lenalidomide is classified as pregnancy category X because it can cause severe fetal harm. It is contraindicated in pregnancy, and women of child‑bearing potential must use effective contraception. Breastfeeding is not recommended while taking lenalidomide.
How do I order Kleder from GNH USA?+
To order Kleder, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Kleder compare with other treatments for multiple myeloma?+
Kleder (lenalidomide) belongs to the immunomodulatory drug class, offering a distinct mechanism from proteasome inhibitors or monoclonal antibodies. It is often used in combination regimens and provides oral administration, which can be advantageous over injectable alternatives for certain patient populations.
What are the recommended storage conditions for Kleder?+
Kleder should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Keep the product in a dry place and avoid exposing it to excessive heat or humidity to maintain its stability.
How is Kleder administered?+
Kleder is taken orally, usually as a tablet swallowed with water. The exact timing (e.g., with or without food) and frequency are set by the prescriber, and patients should adhere to the prescribed schedule for optimal efficacy.
What are the most serious risks associated with Kleder?+
The most serious risks include venous thromboembolism, severe neutropenia or thrombocytopenia that can lead to infections or bleeding, and embryo‑fetal toxicity. Patients should be monitored regularly for blood‑cell counts and signs of clotting, and pregnancy must be avoided.
Who should not use Kleder?+
Kleder should not be used by pregnant women, individuals with known hypersensitivity to lenalidomide, or patients with uncontrolled infections. Caution is also advised for those with severe renal impairment or a history of thrombotic events.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Lenalidomide
Route
Oral Use
Manufacturer
Eg S.P.A.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU